Skip to main content
Barry Zingman, MD, Infectious Disease, Bronx, NY, Montefiore Medical Center

BarrySZingmanMD

Infectious Disease Bronx, NY

HIV/AIDS Medicine

Professor, Medicine, Infectious Diseases, Albert Einstein College of Medicine

Dr. Zingman is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Connect with other colleagues in the same hospital or clinic
  • Search all U.S. specialist profiles and refer a patient
  • Read the latest clinical news and earn CME/CEU credits

See Dr. Zingman's full profile

Already have an account?

Education & Training

  • Boston University Medical Center
    Boston University Medical CenterFellowship, Infectious Disease, 1988 - 1991
  • Boston University Medical Center
    Boston University Medical CenterResidency, Internal Medicine, 1985 - 1988
  • New York University School of Medicine
    New York University School of MedicineClass of 1985

Certifications & Licensure

  • null
    null, NY 1991 - 2025
  • American Board of Internal Medicine Internal Medicine
  • American Board of Internal Medicine Infectious Disease

Clinical Trials

Publications & Presentations

PubMed

Journal Articles

  • Remdesivir for the Treatment of Covid-19 — Final Report  
    Aneesh K Mehta, Barry S Zingman, Andre C Kalil, Helen Y Chu, Robert W Finberg, Kerry Dierberg, Victor Tapson, Lanny Hsieh, Thomas F Patterson, Daniel A Sweeney, Willia..., The New England Journal of Medicine

Press Mentions

  • Resverlogix Announces Type C Meeting with FDA for CORAL, a Phase 3 High-Risk COVID-19 Outpatient Study
    Resverlogix Announces Type C Meeting with FDA for CORAL, a Phase 3 High-Risk COVID-19 Outpatient StudyMay 9th, 2022
  • Montefiore Launches Trial for Pill Used to Treat and Possibly Prevent COVID-19
    Montefiore Launches Trial for Pill Used to Treat and Possibly Prevent COVID-19November 8th, 2021
  • Montefiore/Einstein Lead Drug Trial on COVID-19 Antiviral Drug, Merck, Approved in the UK
    Montefiore/Einstein Lead Drug Trial on COVID-19 Antiviral Drug, Merck, Approved in the UKNovember 8th, 2021
  • Join now to see all

Professional Memberships

Hospital Affiliations